全球體液採集與診斷市場

預計到 2030 年全球體液採集和診斷市場規模將達到 463 億美元

全球體液採集和診斷市場規模預計在2024年為333億美元，預計到2030年將達到463億美元，2024年至2030年的複合年成長率為5.6%。血液樣本是本報告分析的細分市場之一，預計其複合年成長率為6.4%，到分析期結束時規模將達到210億美元。唾液樣本細分市場在分析期間內的複合年成長率預計為5.3%。

美國市場規模估計為 91 億美元，中國市場預期複合年成長率為 9.0%

預計2024年，美國體液採集和診斷市場規模將達91億美元。作為世界第二大經濟體的中國，預計2030年市場規模將達到94億美元，在分析期內（2024-2030年）的複合年成長率為9.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為2.7%和5.6%。在歐洲，預計德國的複合年成長率為3.7%。

全球體液收集和診斷市場—主要趨勢和促進因素摘要

哪些創新將改變液體收集和診斷？

由於技術進步提高了診斷的準確性、效率和患者舒適度，體液採集和診斷市場正在經歷快速轉型。微流體和實驗室晶片技術的創新徹底改變了體液分析的方式，使以最少的樣本量進行快速的照護現場診斷成為可能。自動化樣本採集設備和封閉式系統透過降低污染和接觸傳染性物質的風險，提高了安全性。先進的液態切片技術能夠從血液樣本中檢測循環性腫瘤細胞(CTC) 和遊離DNA (cfDNA)，並且正在成為一種非侵入性癌症診斷方法。分子診斷與即時聚合酵素鏈鎖反應(RT-PCR) 和次世代定序(NGS) 技術的結合，正在增強對各種疾病相關病原體、基因突變和生物標記的檢測。持續監測汗液和組織液等體液的穿戴式裝置正變得越來越普及，為慢性病管理提供即時健康數據。此外，用於家庭診斷（尤其是感染疾病和生殖健康診斷）的自採集套件的開發，正在擴大診斷服務的可及性。這些創新正在提高診斷能力，縮短週轉時間，並透過精準的生物標記分析實現個人化醫療。

新興的健康趨勢和最終用途如何推動體液診斷市場？

受新興健康趨勢和人們對早期疾病檢測日益成長的興趣的推動，體液採集和診斷的需求正在醫療保健領域的各個領域不斷擴大。在臨床環境中，體液分析對於感染疾病、代謝紊亂和癌症的診斷至關重要，其應用範圍擴展到血液、尿液、腦脊髓液和滑液的診斷。新冠疫情加速了快速診斷檢測和家用樣本採集試劑套件的普及，凸顯了便利高效的診斷解決方案的重要性。在腫瘤學領域，液態切片技術徹底改變了癌症篩檢和監測，提供了一種非侵入性檢測腫瘤標記和監測治療反應的方法。個人化醫療和標靶治療的興起推動了對能夠識別體液中特定基因突變和生物標記的診斷檢測的需求。此外，運動健身產業正在利用體液診斷來監測體液中的水分含量、電解質平衡和代謝標記物，以最佳化運動表現。在製藥領域，體液分析在臨床試驗、藥物開發和治療監測中發揮關鍵作用。最終用途的多樣化正在推動體液診斷的創新，並增加其在世界各地的採用。

哪些監管和市場動態正在影響體液收集和診斷產業？

體液採集和診斷產業在嚴格的法規環境中運作，旨在確保診斷測試和採集設備的安全性、準確性和可靠性。美國FDA、EMA 和 WHO 等監管機構已製定了全面的診斷核准和監控指南，包括臨床驗證、品管和上市後監管的要求。對診斷準確性和病人安全的日益重視促使人們採用標準化的通訊協定採集、處理和分析協議。市場動態受到就地檢驗(POCT) 需求不斷成長的影響，而這種需求是由急診、偏遠地區和家庭醫療保健環境中對快速診斷的需求所驅動。競爭格局的特點是持續的研發投資、策略聯盟和合併，旨在擴大產品系列和增強技術力。此外，遠端醫療和數位健康平台的興起為遠距離診斷創造了新的機會，患者可以在家中採集檢體並以電子方式獲取結果。報銷政策和監管核准途徑因地區而異，影響市場進入和採用率。這些監管和市場趨勢正在塑造體液診斷的未來，重點是創新、合規性和可及性。

體液收集和診斷市場的成長受到多種因素的推動…

體液採集和診斷市場的成長受到多種因素的推動，包括技術進步、慢性病盛行率上升以及全球對疾病早期發現的關注。分子診斷、微流體和液態切片技術的創新正在提高診斷的準確性並擴大可檢測生物標記的範圍。由於 COVID-19 大流行而加速的就地檢驗和家用檢測的需求不斷成長，導致快速診斷檢測和自我採集套件的採用率不斷提高。感染疾病、癌症和代謝紊亂的負擔日益加重，推動了對能夠及時介入和個人化治療的綜合診斷解決方案的需求。對先進診斷技術的監管支持以及醫療保健投資的增加正在推動市場成長。此外，遠端醫療服務和數位健康平台的擴展正在改善診斷檢測的可近性，尤其是在偏遠和服務不足的地區。診斷公司、醫療保健提供者和研究機構之間的策略聯盟正在推動創新並擴大市場範圍。這些因素，加上正在進行的產品開發、全球健康舉措以及日益增強的預防性醫療保健意識，正在推動體液收集和診斷市場在全球範圍內持續成長。

部分

樣本類型（血液樣本、唾液樣本、尿液樣本、腦脊髓液樣本）、產品類型（套件和耗材、儀器、其他測試/服務）、技術類型（聚合酵素鏈鎖反應、次世代定序、螢光雜合反應、其他技術）、應用（診斷和監測應用、治療決策應用、預後診斷和篩檢應用）

受訪公司範例

• Abbott Laboratories, Inc.
• Becton, Dickinson and Company
• Biocept, Inc.
• BIOMAXIMA SA
• Bio-Rad Laboratories, Inc.
• CTK Biotech, Inc.
• F. Hoffmann-La Roche AG
• Guardant Health, Inc.
• Illumina, Inc.
• Johnson & Johnson Services, Inc.
• Laboratory Corporation of America Holdings
• Mdxhealth SA
• Qiagen, Inc.
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Body Fluid Collection and Diagnostics Market to Reach US$46.3 Billion by 2030

The global market for Body Fluid Collection and Diagnostics estimated at US$33.3 Billion in the year 2024, is expected to reach US$46.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Blood Samples, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$21.0 Billion by the end of the analysis period. Growth in the Saliva Samples segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.1 Billion While China is Forecast to Grow at 9.0% CAGR

The Body Fluid Collection and Diagnostics market in the U.S. is estimated at US$9.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.4 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Body Fluid Collection and Diagnostics Market - Key Trends & Drivers Summarized

What Are the Technological Innovations Transforming Body Fluid Collection and Diagnostics?

The body fluid collection and diagnostics market is undergoing rapid transformation, driven by technological advancements that enhance diagnostic accuracy, efficiency, and patient comfort. Innovations in microfluidics and lab-on-a-chip technologies have revolutionized the way body fluids are analyzed, allowing for rapid, point-of-care diagnostics with minimal sample volumes. Automated sample collection devices and closed-loop systems are improving safety by reducing the risk of contamination and exposure to infectious agents. Advanced liquid biopsy techniques are emerging as a non-invasive alternative for cancer diagnostics, enabling the detection of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) from blood samples. Integration of molecular diagnostics with real-time polymerase chain reaction (RT-PCR) and next-generation sequencing (NGS) technologies is enhancing the detection of pathogens, genetic mutations, and biomarkers associated with various diseases. Wearable devices for continuous monitoring of body fluids such as sweat and interstitial fluid are gaining traction, providing real-time health data for chronic disease management. Additionally, the development of self-collection kits for home-based diagnostics, particularly for infectious diseases and reproductive health, is expanding access to diagnostic services. These technological innovations are improving diagnostic capabilities, reducing turnaround times, and enabling personalized medicine through precise biomarker analysis.

How Are Emerging Health Trends and End-Use Applications Expanding the Body Fluid Diagnostics Market?

The demand for body fluid collection and diagnostics is growing across a wide range of healthcare applications, driven by emerging health trends and the increasing focus on early disease detection. In clinical settings, body fluid analysis is essential for diagnosing infectious diseases, metabolic disorders, and cancers, with applications extending to blood, urine, cerebrospinal fluid, and synovial fluid diagnostics. The COVID-19 pandemic has accelerated the adoption of rapid diagnostic tests and home-based sample collection kits, highlighting the importance of accessible and efficient diagnostic solutions. In oncology, liquid biopsy techniques are revolutionizing cancer screening and monitoring, providing a non-invasive method to detect tumor markers and monitor treatment response. The rise of personalized medicine and targeted therapies has increased the demand for diagnostic tests that can identify specific genetic mutations and biomarkers from body fluids. Additionally, the sports and fitness industry is leveraging body fluid diagnostics to monitor hydration levels, electrolyte balance, and metabolic markers for performance optimization. In the pharmaceutical sector, body fluid analysis plays a critical role in clinical trials, drug development, and therapeutic monitoring. This diversification of end-use applications is driving innovation and expanding the global reach of body fluid diagnostics.

What Regulatory and Market Dynamics Are Shaping the Body Fluid Collection and Diagnostics Industry?

The body fluid collection and diagnostics industry operates within a stringent regulatory environment designed to ensure the safety, accuracy, and reliability of diagnostic tests and collection devices. Regulatory bodies such as the U.S. FDA, EMA, and WHO have established comprehensive guidelines for the approval and monitoring of diagnostic products, including requirements for clinical validation, quality control, and post-market surveillance. The increasing focus on diagnostic accuracy and patient safety has led to the adoption of standardized protocols for sample collection, handling, and analysis. Market dynamics are influenced by the growing demand for point-of-care testing (POCT), driven by the need for rapid diagnostics in emergency care, remote settings, and home healthcare environments. The competitive landscape is marked by continuous R&D investments, strategic partnerships, and mergers aimed at expanding product portfolios and enhancing technological capabilities. Additionally, the rise of telemedicine and digital health platforms has created new opportunities for remote diagnostics, enabling patients to collect samples at home and receive results electronically. Reimbursement policies and regulatory approval pathways vary across regions, influencing market access and adoption rates. These regulatory and market trends are shaping the future of body fluid diagnostics, emphasizing innovation, compliance, and accessibility.

The Growth in the Body Fluid Collection and Diagnostics Market Is Driven by Several Factors…

The growth in the body fluid collection and diagnostics market is driven by several factors, including technological advancements, increasing prevalence of chronic diseases, and the global focus on early disease detection. Innovations in molecular diagnostics, microfluidics, and liquid biopsy technologies are enhancing diagnostic accuracy and expanding the range of detectable biomarkers. The rising demand for point-of-care testing and home-based diagnostics, accelerated by the COVID-19 pandemic, has increased the adoption of rapid diagnostic tests and self-collection kits. The growing burden of infectious diseases, cancer, and metabolic disorders is driving the need for comprehensive diagnostic solutions that enable timely intervention and personalized treatment. Regulatory support for advanced diagnostic technologies, along with increasing healthcare investments, is facilitating market growth. Additionally, the expansion of telehealth services and digital health platforms is enhancing access to diagnostic testing, particularly in remote and underserved regions. Strategic collaborations between diagnostic companies, healthcare providers, and research institutions are fostering innovation and expanding market reach. These factors, combined with continuous product development, global health initiatives, and increasing awareness of preventive healthcare, are propelling the body fluid collection and diagnostics market toward sustained growth worldwide.

SCOPE OF STUDY:

The report analyzes the Body Fluid Collection and Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sample Type (Blood Samples, Saliva Samples, Urine Samples, Cerebrospinal Fluid Samples); Product Type (Kits and Consumables, Instruments, Other Tests/Services); Technology Type (Polymerase Chain Reaction, Next Generation Sequencing, Fluorescence In situ Hybridization, Other Technologies); Application (Diagnostics and Monitoring Application, Therapeutic Decision Making Application, Prognostics and Screening Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories, Inc.
• Becton, Dickinson and Company
• Biocept, Inc.
• BIOMAXIMA S.A.
• Bio-Rad Laboratories, Inc.
• CTK Biotech, Inc.
• F. Hoffmann-La Roche AG
• Guardant Health, Inc.
• Illumina, Inc.
• Johnson & Johnson Services, Inc.
• Laboratory Corporation of America Holdings
• Mdxhealth SA
• Qiagen, Inc.
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Body Fluid Collection and Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases and Infectious Conditions Drives Demand for Advanced Fluid Collection Technologies
  • Growing Emphasis on Early Disease Detection Propels Market for Rapid and Point-of-Care Diagnostic Solutions
  • Advancements in Microfluidics and Lab-on-a-Chip Technologies Transform Fluid Diagnostics Capabilities
  • Surging Demand for Home-Based and Self-Testing Kits Expands the Consumer Diagnostics Market
  • Integration of AI and Machine Learning in Fluid Sample Analysis Enhances Diagnostic Accuracy
  • Increasing Adoption of Liquid Biopsy for Cancer Detection Strengthens Market Growth Potential
  • Rising Global Focus on Pandemic Preparedness and Disease Surveillance Accelerates Innovations in Fluid Collection
  • Expansion of Personalized Medicine and Precision Diagnostics Spurs Demand for Advanced Biomarker Analysis
  • Miniaturization and Automation of Sample Processing Improve Speed and Efficiency in Diagnostics
  • Development of Smart Biosensors Enhances the Potential for Real-Time Health Monitoring
  • Surging Demand for Blood and Plasma Testing in Drug Development and Clinical Trials Expands Market Scope
  • Point-of-Care Testing (POCT) Growth in Emerging Markets Strengthens Business Case for Portable Fluid Diagnostics
  • Rising Awareness of Preventive Healthcare Spurs Market for Routine Fluid Analysis Tests
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Body Fluid Collection and Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Saliva Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Saliva Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Saliva Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Urine Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Urine Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Urine Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cerebrospinal Fluid Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cerebrospinal Fluid Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Fluorescence In situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Fluorescence In situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Fluorescence In situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Next Generation Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Next Generation Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Next Generation Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostics & Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Diagnostics & Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Diagnostics & Monitoring Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Therapeutic Decision Making Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Therapeutic Decision Making Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Therapeutic Decision Making Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Prognostics & Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Prognostics & Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Prognostics & Screening Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Kits & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Kits & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Kits & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Tests / Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Tests / Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other Tests / Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• JAPAN
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• CHINA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• EUROPE
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• FRANCE
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• GERMANY
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• INDIA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• AFRICA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030

IV. COMPETITION